Olivier Boucherat
Overview
Explore the profile of Olivier Boucherat including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
92
Citations
1842
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
21.
Lemay S, Boucherat O, Bonnet S
JACC Basic Transl Sci
. 2022 Aug;
7(7):678-680.
PMID: 35958692
No abstract available.
22.
Chelladurai P, Kuenne C, Bourgeois A, Gunther S, Valasarajan C, Cherian A, et al.
Sci Transl Med
. 2022 Jun;
14(648):eabe5407.
PMID: 35675437
Phenotypic alterations in resident vascular cells contribute to the vascular remodeling process in diseases such as pulmonary (arterial) hypertension [P(A)H]. How the molecular interplay between transcriptional coactivators, transcription factors (TFs),...
23.
Shimauchi T, Boucherat O, Yokokawa T, Grobs Y, Wu W, Orcholski M, et al.
JACC Basic Transl Sci
. 2022 May;
7(4):384-403.
PMID: 35540097
The authors show that increased poly(adenosine diphosphate-ribose) polymerase 1 (PARP1) and pyruvate kinase muscle isozyme 2 (PKM2) expression is a common feature of a decompensated right ventricle in patients with...
24.
Boucherat O, Agrawal V, Lawrie A, Bonnet S
Circ Res
. 2022 Apr;
130(9):1466-1486.
PMID: 35482834
Pulmonary hypertension (PH) describes heterogeneous population of patients with a mean pulmonary arterial pressure >20 mm Hg. Rarely, PH presents as a primary disorder but is more commonly part of...
25.
Provencher S, Potus F, Blais-Lecours P, Bernard S, Martineau S, Breuils-Bonnet S, et al.
Am J Respir Crit Care Med
. 2022 Mar;
205(11):1357-1360.
PMID: 35289736
No abstract available.
26.
Kudryashova T, Dabral S, Nayakanti S, Ray A, Goncharov D, Avolio T, et al.
Circ Res
. 2022 Feb;
130(5):760-778.
PMID: 35124974
Rationale: The MSTs (mammalian Ste20-like kinases) 1/2 are members of the HIPPO pathway that act as growth suppressors in adult proliferative diseases. Pulmonary arterial hypertension (PAH) manifests by increased proliferation...
27.
Wu W, Bonnet S, Shimauchi T, Toro V, Grobs Y, Romanet C, et al.
Thorax
. 2021 Jul;
77(3):247-258.
PMID: 34226205
Background: Idiopathic pulmonary fibrosis (IPF) is a chronic lung disease characterised by exuberant tissue remodelling and associated with high unmet medical needs. Outcomes are even worse when IPF results in...
28.
Lemay S, Awada C, Shimauchi T, Wu W, Bonnet S, Provencher S, et al.
Cells
. 2021 Jul;
10(6).
PMID: 34208388
Pulmonary arterial hypertension is a debilitating chronic disorder marked by the progressive obliteration of the pre-capillary arterioles. This imposes a pressure overload on the right ventricle (RV) pushing the latter...
29.
Grobs Y, Awada C, Lemay S, Romanet C, Bourgeois A, Toro V, et al.
Int J Mol Sci
. 2021 Apr;
22(6).
PMID: 33805714
Trifluoperazine (TFP), an antipsychotic drug approved by the Food and Drug Administration, has been show to exhibit anti-cancer effects. Pulmonary arterial hypertension (PAH) is a devastating disease characterized by a...
30.
Habbout K, Omura J, Awada C, Bourgeois A, Grobs Y, Krishna V, et al.
Int J Mol Sci
. 2021 Apr;
22(6).
PMID: 33803922
Pulmonary arterial hypertension (PAH) is a progressive disorder characterized by a sustained elevation of pulmonary artery (PA) pressure, right ventricular failure, and premature death. Enhanced proliferation and resistance to apoptosis...